Showing posts with label Overactive Bladder Therapeutics Market Trends 2014-2018. Show all posts
Showing posts with label Overactive Bladder Therapeutics Market Trends 2014-2018. Show all posts

Tuesday, 16 December 2014

Global Overactive Bladder Therapeutics Market to see 1.14% CAGR Globally by 2018, says a Research Report available at Research Beam

Report Overview

Research Beam adds a report titled “Global Overactive Bladder Therapeutics Market 2014-2018”. The report forecast the global overactive bladder therapeutics market to register a CAGR of 1.14% during the forecast period i.e. 2013-2018.

Overactive bladder also known as overactive bladder syndrome refers to urological disorder, which is related with the urination problems. The symptoms of overactive bladder are urgency, urinary incontinence, nocturia or change in frequency of urination. Overactive bladder disorder is caused due to the abnormal contraction of the urinary detrusor muscles of the bladder.


The urological disorder can affect a person irrespective of the gender; however, the major population suffering from overactive bladder are women. This disorder does not pose any major threat to the life of the patient, however, it affects the quality and stability in an individual’s life. There are various forms of treatments and medicines recommended by the health officials to treat such conditions.

The report on overactive bladder therapeutics defines and explains the various market trends, drivers & restraints, types and technologies involved in the overactive bladder therapeutics market. Some of the various types of treatments included in the report are Anti-muscarinic Agent and Beta-3-Adrenergic Receptor Agonist.

The rise in the number of geriatric population is the major a factor driving the growth of the overall global overactive bladder therapeutics market. Also, the increasing awareness related to the disorder among people across the globe would further propel the market growth. However, difficulty in diagnosing the overactive bladder disorder is the major challenge for the overall market.

Get Full Details On:
http://www.researchbeam.com/global-overactive-bladder-therapeutics-2014-2018-market

The report consist of in-depth analysis of the competitive structure and growth prospects of the overactive bladder therapeutics market across various geographical regions such as America, APAC and EMEA.

Companies profiled in the report are:
• Allergan
• Actavis
• Addex Therapeutics
• Astellas Pharma
• Pfizer
• AltheRx Pharmaceuticals
• American Oriental Bioengineering
• Antares Pharma
• Apogepha Arzneimittel
• Auxilium Pharmaceuticals
• Bayer
• elbion
• FemmePharma
• Ferring Pharmaceuticals
• GlaxoSmithKline
• Hisamitsu Pharmaceutical
• Hydra Biosciences
• Ion Channel Innovations
• Ipsen
• Janssen
• Kissei Pharma
• Kwang Dong Pharmaceutical
• KYORIN Pharma
• Laboratorios SALVAT
• LG Life Sciences
• Lipella Pharmaceuticals
• Merck
• Motif BioSciences

For More Information Kindly Contact:
Call Us :
Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555

Or Mail Us :
sales@researchbeam.com

Visit Our Blog :
http://researchbeam.blogspot.com/